During the past decade, Central Illinois CCOP conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Illinois CCOP" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Central Illinois CCOP" are "Adenocarcinoma of the Gastroesophageal Junction" (1 trials), "Esophageal Cancer" (1 trials), "Extrahepatic Bile Duct Adenocarcinoma" (1 trials), "Gallbladder Adenocarcinoma" (1 trials) and "Gallbladder Adenocarcinoma With Squamous Metaplasia" (1 trials). Many other conditions were trialed in "Central Illinois CCOP" in a lesser frequency.

Most popular intervention types in "Central Illinois CCOP" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Akt Inhibitor MK2206" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Cetuximab" (1 trials) and "Erlotinib Hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Illinois CCOP" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Central Illinois CCOP". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Central Illinois CCOP, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Central Illinois CCOP, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".